Oragenics INC (OGEN) — 10-Q Filings

10-Q Filings (6)

• Oragenics' Cash Surges on $15.2M Offering, But Losses Persist — Nov 7, 2025 Risk: high
  Oragenics Inc. reported a net loss of $7.56 million for the nine months ended September 30, 2025, compared to a net loss of $7.22 million for the same period in
• Oragenics Reports No Revenue, Deepening Losses Amid Capital Raises — Aug 8, 2025 Risk: high
  Oragenics Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, indicating its pre-commercial stage
• Oragenics Files Q1 2025 10-Q Report — May 9, 2025 Risk: medium
  Oragenics Inc. filed its Q1 2025 10-Q report on May 9, 2025, covering the period ending March 31, 2025. The company, based in Sarasota, FL, operates in the phar
• Oragenics Inc. Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  Oragenics Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position, including its prefe
• Oragenics Inc. Files Q2 2024 10-Q Report — Aug 9, 2024 Risk: low
  Oragenics Inc. filed its 10-Q for the period ending June 30, 2024. The company, based in Sarasota, Florida, operates in the pharmaceutical preparations sector.
• Oragenics Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  ORAGENICS INC (OGEN) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Oragenics Inc. filed a 10-Q report for the quarterly period ended March 31, 2

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX